Integrated Imaging Using MRI and 123| Metaiodobenzylguanidine Scintigraphy to Improve Sensitivity and Specificity in the Diagnosis of Pediatric Neuroblastoma
- 1 October 2003
- journal article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 181 (4) , 1115-1124
- https://doi.org/10.2214/ajr.181.4.1811115
Abstract
OBJECTIVE. The objectives of this study were to compare MRI and iodine-123 (123I) metaiodobenzylguanidine (MIBG) scintigraphy in the detection of neuroblastoma lesions in pediatric patients and to assess the additional value of combined imaging. MATERIALS AND METHODS. Fifty MRI and 50 123I MIBG examinations (mean interval, 6.4 days) were analyzed retrospectively with regard to suspected or proven neuroblastoma lesions (n = 193) in 28 patients. MRI and MIBG scans were reviewed by two independent observers each. Separate and combined analyses of MRI and MIBG scintigraphy were compared with clinical and histologic findings. RESULTS. With regard to the diagnosis of neuroblastoma lesion, MIBG scintigraphy, MRI, and combined analysis showed a sensitivity of 69%, 86%, and 99% and a specificity of 85%, 77%, and 95%, respectively. On MRI, 15 false-positive findings were recorded: posttherapeutic reactive changes (n = 10), benign adrenal tumors (n = 3), and enlarged lymph nodes (n = 2). On MIBG scintigraphy, 10 false-positive findings occurred: ganglioneuromas (n = 2), benign liver tumors (n = 2), and physiologic uptake (n = 6). Thirteen neuroblastoma metastases and two residual masses under treatment with chemotherapy were judged to be false-negative findings on MRI. Two primary or residual neuroblastomas and one orbital metastasis were misinterpreted as Wilms' tumor, reactive changes after surgery, and rhabdomyosarcoma on MRI. Thirty-two bone metastases, six other neuroblastoma metastases, and one adrenal neuroblastoma showed no MIBG uptake. On combined imaging, one false-negative (bone metastasis) and three false-positive (two ganglioneuromas and one pheochromocytoma) findings remained. CONCLUSION. In the assessment of neuroblastoma lesions in pediatric patients, MRI showed a higher sensitivity and MIBG scintigraphy a higher specificity. However, integrated imaging showed an increase in both sensitivity and specificity.Keywords
This publication has 23 references indexed in Scilit:
- False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastomaMedical and Pediatric Oncology, 2000
- Imaging of Abdominal Neuroblastoma in ChildrenActa Radiologica, 1999
- Adrenal neuroblastoma in an adult with tumor thrombus in the inferior vena cavaJournal of Magnetic Resonance Imaging, 1999
- Magnetic resonance imaging of neuroblastoma using current techniquesMagnetic Resonance Imaging, 1999
- Blindness in children with neuroblastomaCancer, 1997
- Meta-iodobenzylguanidine in childrenSeminars in Nuclear Medicine, 1993
- Abdominale Tumoren beim KindRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 1993
- Efficacy of Metaiodobenzylguanidine as a Scintigraphic Agent for the Detection of NeuroblastomaInvestigative Radiology, 1992
- The diagnostic and therapeutic utility of radioiodinated metaiodobenzy1guanidine (MIBG)European Journal of Nuclear Medicine and Molecular Imaging, 1990
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981